abstract |
The present invention relates to a method of treating liver diseases. The methods include administering a therapeutically effective amount of at least one FXR agonist and a therapeutically effective amount of SAMe. In various embodiments, the at least one FXR agonist and SAMe are administered sequentially or simultaneously. |